Back |
home / stock / amrx / amrx message board
Subject | By | Source | When |
---|---|---|---|
$AMRX is just cruising along and laying low | ListenToMe | investorshub | 08/17/2020 12:46:57 PM |
Now you're talking!! I like the sound of that. | ListenToMe | investorshub | 08/12/2020 6:05:23 PM |
Shorts cover, approval for biosimilar meds, or Kodaks | dangerx | investorshub | 08/12/2020 6:04:11 PM |
So I'm trying to figure out what would | ListenToMe | investorshub | 07/20/2020 3:20:23 PM |
Lots of interest in $AMRX. | ListenToMe | investorshub | 07/02/2020 10:30:41 AM |
Things havent even got going yet... This is | dangerx | investorshub | 06/16/2020 5:18:43 AM |
And.... HERE WE GO!!$$$ | ListenToMe | investorshub | 06/09/2020 5:10:14 PM |
Looking Very Strong!! | ListenToMe | investorshub | 06/08/2020 6:00:39 PM |
Can't go wrong with $AMRX!!! | ListenToMe | investorshub | 06/06/2020 7:29:20 PM |
Can't go wrong with $AMRX!!! | ListenToMe | investorshub | 06/06/2020 7:28:48 PM |
$AMRX... $5.00 - $10.00 - $50.00 - $100+ !!!$$$$ | ListenToMe | investorshub | 05/26/2020 6:27:10 PM |
$182 was the price target last year for | ListenToMe | investorshub | 05/25/2020 1:02:38 PM |
Insiders are loading $AMRX. | ListenToMe | investorshub | 05/25/2020 12:50:50 PM |
Thanks for the feedback. | ClayTrader | investorshub | 05/18/2020 1:20:42 PM |
Add some commentary instead of just advertising your | dangerx | investorshub | 05/18/2020 12:29:05 PM |
News, Short Squeeze, Breakout and More Instantly...
Amneal Pharmaceuticals Inc. Class A Company Name:
AMRX Stock Symbol:
NYSE Market:
Amneal Pharmaceuticals Inc. Class A Website:
Amneal Pharmaceuticals, Inc. (NASDAQ: AMRX) announced today that the Company will release its second quarter 2024 financial results on Friday, August 9, 2024, prior to market open. The Company will host a conference call and live webcast with the investment community at 8:30 a.m. Eastern Time. ...
FOCINVEZ (fosaprepitant) 150 mg/50 mL single dose vial is an anti-nausea agent for highly emetogenic and moderately emetogenic chemotherapy (HEC and MEC) Second injectable RTU product launched by Amneal in 2024 Amneal Pharmaceuticals, Inc. (NASDAQ: AMRX) (“Amneal”...
Builds on successful U.S. biosimilar partnership of 2 oncology products (RELEUKO ® & FYLNETRA ® ) ADL018 is Kashiv’s lead pipeline biosimilar program, currently in Phase III Kashiv BioSciences, LLC (“Kashiv” or the “Companyȁ...